author-photo

Bernardo De Miguel

7

Papers

103

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

RBD-Specific Polyclonal F(ab´) 2 Fragments of Equine Antibodies in Patients with Moderate to Severe COVID-19 Disease: A Randomized, Double-Blind, Placebo-Controlled, Adaptive Phase 2/3 Clinical Trial

2021
Show All
- Source
- Cite
- Save
Citations (1)
RBD-specific polyclonal F(ab´) 2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial.

2021 EClinicalMedicine
Show All
- Source
- Cite
- Save
Citations (15)
Phase I dose-finding and pharmacokinetic study of a combination of elisidepsin (E) and erlotinib (T) in patients (pts) with advanced solid tumors.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Results of the randomized phase III trial of trabectedin (T) versus doxorubicin-based chemotherapy (DXCT) as first-line therapy in patients (pts) with translocation-related sarcoma (TRS).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin’s lymphoma

2013 Haematologica
Show All
- Source
- Cite
- Save
Citations (47)
A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: An Innovative Therapies for Children with Cancer (ITCC) study

2012 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (30)